← All patents

US12247206B2

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune …

University of Texas System

Abstract

The present invention includes compositions and methods for treating an autoimmune disorder or a cancer in a subject in need thereof, the method comprising: administering an effective amount of a composition comprising an oligonucleotide that specifically binds a complementary sequence of the …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Mariano A. Garcia-Blanco
Priority date
March 22, 2018
Filing date
October 16, 2023
Grant date
March 11, 2025
Publication date
March 11, 2025
Language
en
Metadata fetched
August 29, 2026 00:34